BeyondSpring Inc. (BYSI)
Last updated: 2026-11-03 22:21:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
BeyondSpring Inc. (BYSI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.64, with a market capitalization of $26.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.42 to $2.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$26.47M | |
$0.77 | |
$48.49 | |
$0.42 | |
$0.81 | |
229.58K | |
898.43K | |
-- | |
$2.44 | |
$0.42 | |
-- | |
-- |
BeyondSpring Inc. (BYSI) After-Hours Stock Price
BeyondSpring Inc. (BYSI) is trading at $0.69 in after-hours trading as of 2026-11-03 22:19:00, down 14.51% ($0.12) from the regular-session close of $0.81.
After-hours trading shows how investors are pricing BYSI after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
BeyondSpring Inc. (BYSI) 7-Day Stock Price Change
Over the past seven days, BeyondSpring Inc. (BYSI) moved from $0.43 to $0.64, representing a gain of 47.76% ($0.21).
The stock traded between $0.42 and $0.90 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 267.43 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BYSI 52-Week Price Position
Position in Range: 10.7%
BYSI is currently trading at $0.64, placing it 10.7% of the way from its 52-week low of $0.42 to its 52-week high of $2.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BeyondSpring Inc. (BYSI)?
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
BeyondSpring Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
How to Buy BeyondSpring Inc. (BYSI) Stock on MEXC
Eligible investors can buy real shares of BeyondSpring Inc. (BYSI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BeyondSpring Inc. (BYSI) stock price today?
2.Is BYSI stock going up or down today?
3.What is BYSI pre-market price?
4.What is BYSI after-hours price?
5.Is BYSI stock trading now?
6.Where does BYSI sit relative to its 52-week high and low?
7.What sector is BeyondSpring Inc. in?
8.What is BeyondSpring Inc.'s market capitalization and where is it listed?
9.How is BYSI valued in terms of P/E ratio and EPS?
10.Does BeyondSpring Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BYSI Stock Calculator
Estimate the value between BYSI shares and USD.
BYSI Shares to USD
1.00 BYSI shares = 0.637 USD
Calculations are estimates based on the latest available price and are for reference only.



